Akron Biotech Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 123

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 5

  • Investments
  • 1

Akron Biotech General Information

Description

Developer and producer of regenerative medicine intended to improve human well-being. The company specializes in offering validated and compliant technologies, products, and services to the cell and gene therapy and regenerative medicine arena, through constant research and developments, enabling the medical industry and consumers to cure cell and gene-related illnesses at a nominal cost.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 6353 West Rogers Circle
  • Suite 2
  • Boca Raton, FL 33487
  • United States
+1 (561)
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 6353 West Rogers Circle
  • Suite 2
  • Boca Raton, FL 33487
  • United States
+1 (561)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Akron Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Akron Biotech‘s full profile, request access.

Request a free trial

Akron Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer and producer of regenerative medicine intended to improve human well-being. The company specializes in offerin
Other Pharmaceuticals and Biotechnology
Boca Raton, FL
123 As of 2024

Wilmington, MA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Akron Biotech Competitors (72)

One of Akron Biotech’s 72 competitors is Charles River Laboratories International, a Formerly PE-Backed company based in Wilmington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Charles River Laboratories International Formerly PE-Backed Wilmington, MA
Cell Applications Corporation San Diego, CA
Miltenyi Biotec Private Debt Financed Bergisch Gladbach, Germany
MORAGA BIOTECHNOLOGY CORPORATION Corporation Los Angeles, CA
ProMab Biotechnologies Corporate Backed or Acquired Richmond, CA
You’re viewing 5 of 72 competitors. Get the full list »

Akron Biotech Patents

Akron Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020256246-A1 Cryopreservation and cell culture media Inactive 03-Apr-2019
CA-3135852-A1 Cryopreservation and cell culture media Pending 03-Apr-2019
EP-3945815-A4 Cryopreservation and cell culture media Pending 03-Apr-2019
US-20220159945-A1 Cryopreservation and cell culture media Pending 03-Apr-2019
JP-2022526983-A Cryopreservation and cell culture medium Pending 03-Apr-2019 A01N1/126
To view Akron Biotech’s complete patent history, request access »

Akron Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Akron Biotech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Akron Biotech‘s full profile, request access.

Request a free trial

Akron Biotech Acquisitions (1)

Akron Biotech’s most recent deal was a Merger/Acquisition with AppliChem. The deal was made on 03-Mar-2009.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
AppliChem 03-Mar-2009 Merger/Acquisition Other Chemicals and Gases
To view Akron Biotech’s complete acquisitions history, request access »

Akron Biotech Exits (1)

Akron Biotech’s most recent exit was on 03-Mar-2009 from AppliChem. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
AppliChem 03-Mar-2009 Completed
To view Akron Biotech’s complete exits history, request access »

Akron Biotech FAQs

  • When was Akron Biotech founded?

    Akron Biotech was founded in 2006.

  • Where is Akron Biotech headquartered?

    Akron Biotech is headquartered in Boca Raton, FL.

  • What is the size of Akron Biotech?

    Akron Biotech has 123 total employees.

  • What industry is Akron Biotech in?

    Akron Biotech’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Akron Biotech a private or public company?

    Akron Biotech is a Private company.

  • What is Akron Biotech’s current revenue?

    The current revenue for Akron Biotech is .

  • Who are Akron Biotech’s investors?

    Arcline (Private Equity) and National Institute of General Medical Sciences have invested in Akron Biotech.

  • Who are Akron Biotech’s competitors?

    Charles River Laboratories International, Cell Applications, Miltenyi Biotec, MORAGA BIOTECHNOLOGY CORPORATION, and ProMab Biotechnologies are some of the 72 competitors of Akron Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »